MedKoo Cat#: 414294 | Name: Batebulast

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Batebulast is a Histamine H1 Antagonist.

Chemical Structure

Batebulast
Batebulast
CAS#81907-78-0

Theoretical Analysis

MedKoo Cat#: 414294

Name: Batebulast

CAS#: 81907-78-0

Chemical Formula: C19H29N3O2

Exact Mass: 331.2260

Molecular Weight: 331.46

Elemental Analysis: C, 68.85; H, 8.82; N, 12.68; O, 9.65

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Batebulast; NCO650; NCO-650; NCO 650
IUPAC/Chemical Name
p-tert-Butylphenyl trans-4-(guanidinomethyl)cyclohexanecarboxylate
InChi Key
HXLJIJAWKVNQNT-HDJSIYSDSA-N
InChi Code
InChI=1S/C19H29N3O2/c1-19(2,3)15-8-10-16(11-9-15)24-17(23)14-6-4-13(5-7-14)12-22-18(20)21/h8-11,13-14H,4-7,12H2,1-3H3,(H4,20,21,22)/t13-,14-
SMILES Code
O=C([C@H]1CC[C@H](CNC(N)=N)CC1)OC2=CC=C(C(C)(C)C)C=C2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 331.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Misawa M, Takenouchi K, Sato M, Yanaura S. The effect of trans-4-guanidinomethylcyclohexanecarboxylic acid p-tert-butylphenyl ester hydrochloride (NCO-650) on Ascaris suum antigen-induced bronchoconstriction in dogs. Jpn J Pharmacol. 1987 Jan;43(1):53-60. doi: 10.1254/jjp.43.53. PMID: 2437348. 2: Akagi M, Mio M, Tasaka K. Histamine release inhibition and prevention of the decrease in membrane fluidity induced by certain anti-allergic drugs: analysis of the inhibitory mechanism of NCO-650. Agents Actions. 1983 Apr;13(2-3):149-56. doi: 10.1007/BF01967320. PMID: 6191546. 3: Nakayama S, Kawashima I, Kasahara T, Sakamoto K. Effects of p-tert- butylphenyl trans-4-guanidinomethylcyclohexane carboxylate hydrochloride (NCO-650) and its metabolite, p-tert-butylphenol(BP) on drug-metabolizing enzymes and fine structure in rat liver. J Toxicol Sci. 1988 May;13(2):71-81. doi: 10.2131/jts.13.71. PMID: 3172284. 4: Nakayama S, Kawashima I, Kasahara T, Sakamoto K. [Effect of p-tert- butylphenyl trans-4-guanidinomethyl cyclohexane carboxylate hydrochloride (NCO-650) on drug-metabolizing enzymes and fine structure in rat liver]. J Toxicol Sci. 1985 Aug;10(3):187-98. Japanese. doi: 10.2131/jts.10.187. PMID: 2866255. 5: Takei M, Matumoto T, Endo K, Muramatu M. Inhibitory effect of anti-allergic agent NCO-650 on histamine release induced by various secretagogues. Agents Actions. 1988 Aug;25(1-2):17-21. doi: 10.1007/BF01969088. PMID: 2461059. 6: Arakawa K, Tonooka M, Goto H, Sakamoto K. Membrane stabilizing action of NCO-650 and its congeners. Jpn J Pharmacol. 1984 Nov;36(3):311-8. doi: 10.1254/jjp.36.311. PMID: 6441049. 7: Misawa M, Takenouchi K, Sato M, Yanaura S. The effects of chlorpheniramine and antiallergic drugs on Ascaris suum antigen-induced active cutaneous anaphylaxis in dogs. Jpn J Pharmacol. 1987 May;44(1):101-4. doi: 10.1254/jjp.44.101. PMID: 2442443. 8: Misawa M, Takenouchi K, Shirakawa Y, Yanaura S. Effects of mast cell stabilizers on a new bronchial asthma model using compound 48/80 in dogs. Jpn J Pharmacol. 1987 Jun;44(2):197-205. doi: 10.1254/jjp.44.197. PMID: 2443734. 9: Takei M, Matumoto T, Endo K, Muramatu M. Inhibition of phospholipid methylation by an anti-allergic agent, NCO-650, during histamine release. Biochem Pharmacol. 1990 Oct 15;40(8):1773-8. doi: 10.1016/0006-2952(90)90355-o. PMID: 1978677. 10: Takei M, Matumoto T, Endo K, Muramatu M. Inhibition of cAMP increase by an anti-allergic agent, NCO-650, during histamine release. Int Arch Allergy Appl Immunol. 1989;88(4):377-80. doi: 10.1159/000234720. PMID: 2470687.